Extract to table

The regulatory environment for molecular diagnostics is highly dynamic — CMS and the MolDx program regularly issue guidance, revise LCD criteria, and adjust program requirements — and GDT's coverage strategy must remain responsive to these developments

Coordination with GDT's Other Advisors We recognize that an engagement of this nature does not occur in isolation — GDT's Medicare coverage and coding strategy must be developed in coordination with a number of other advisors and consultants whose work product will interface with the engagement